Home-Based Pulmonary Rehabilitation for Interstitial Lung Disease

Overseen By Benjamin Thomas

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Mayo Clinic

Disqualifiers: Inability to walk, Cognitive impairment, Hospice, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 12 weeks

81 Participants Needed

Trial Summary

What is the purpose of this trial?

The purpose of this study is to gather information on the effectiveness of a home-based pulmonary rehabilitation program with health coaching and tele-monitoring for improving patient-reported respiratory-related quality of life and physical activity in patients with fibrotic Interstitial Lung Diseases (f-ILD).

Research Team

Teng Moua, MD

Principal Investigator

Mayo Clinic

Eligibility Criteria

This trial is for people with a type of lung scarring called fibrotic Interstitial Lung Diseases who feel significantly short of breath. They must have at least 10% lung fibrosis visible on CT scans and be able to understand the study's instructions. It's not for those who've recently done pulmonary rehab, are in hospice care, currently experiencing a flare-up of symptoms, or can't walk due to other health issues.

Inclusion Criteria

I often feel short of breath doing daily activities.

I have been diagnosed with a lung scarring disease with more than 10% fibrosis.

Exclusion Criteria

I completed my physical rehabilitation within the last 3 months.

My condition is worsening right now.

I can understand and follow instructions.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in a home-based pulmonary rehabilitation program with health coaching and tele-monitoring, including gentle upper body exercises, walking, and breathing practice for 12 weeks.

12 weeks

Weekly check-in calls (telephone)

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments of respiratory-related quality of life and physical activity.

4 weeks

Treatment Details

Interventions

• Home-based pulmonary rehabilitation

Trial Overview The study tests if doing pulmonary rehabilitation at home with health coaching and monitoring through technology can improve how patients with lung scarring diseases feel about their breathing and increase their physical activity.

Participant Groups

Group I: Home-based pulmonary rehab for fibrotic interstitial lung disease Experimental Treatment 1 Intervention

Subjects diagnosed with fibrotic interstitial lung disease will participate in a home-rehab program that promotes more physical activity in daily life.

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials

3,427

Recruited

3,221,000+

Boehringer Ingelheim

Industry Sponsor

Trials

2,566

Recruited

16,150,000+